Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs
- DOI
- 10.1016/j.toxrep.2024.101825
- Published
- 2024-12
- Container
- Toxicology Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.toxrep.2024.101825,
title = {Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs},
author = {Ochuko L. Erukainure and Aliyu Muhammad and Rahul Ravichandran and Musa M. Abarshi and Sanusi B. Katsayal and Murtala B. Abubakar and Ya'qub U. Abiodun and Olubunmi Atolani and Robert Preissner and Priyanka Banerjee},
year = {2024},
journal = {Toxicology Reports},
doi = {10.1016/j.toxrep.2024.101825},
url = {https://doi.org/10.1016/j.toxrep.2024.101825}
}RIS
TY - JOUR TI - Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs AU - Ochuko L. Erukainure AU - Aliyu Muhammad AU - Rahul Ravichandran AU - Musa M. Abarshi AU - Sanusi B. Katsayal AU - Murtala B. Abubakar AU - Ya'qub U. Abiodun AU - Olubunmi Atolani AU - Robert Preissner AU - Priyanka Banerjee PY - 2024 JO - Toxicology Reports DO - 10.1016/j.toxrep.2024.101825 UR - https://doi.org/10.1016/j.toxrep.2024.101825 ER -
APA
Erukainure, O. L., Muhammad, A., Ravichandran, R., Abarshi, M. M., Katsayal, S. B., Abubakar, M. B., Abiodun, Y. U., Atolani, O., Preissner, R., & Banerjee, P. (2024). Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs. Toxicology Reports. https://doi.org/10.1016/j.toxrep.2024.101825
Source records
- crossref · retrieved 2026-09-25T10:28:10.541Z